Neoleukin Therapeutics Inc (NASDAQ:NLTX)

4.00
Delayed Data
As of 3:59pm ET
 -0.02 / -0.50%
Today’s Change
1.88
Today|||52-Week Range
4.70
+57.17%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Neoleukin Therapeutics Inc have a median target of 7.50, with a high estimate of 7.50 and a low estimate of 7.50. The median estimate represents a +87.50% increase from the last price of 4.00.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Hold stock in Neoleukin Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.03
Sales
$0.00
Reporting Date
Nov 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 85.00%
 
 
 
 
 
 
Growthannually 93.85%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.